Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-24

Clinical Trial Update: Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing venlafaxine to dosulepin for pain-predominant somatic symptom disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dosulepin (dosulepin)
  • Venlafaxine (Venlafaxine)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Somatic Symptom Disorder (DSM-V) | Phase 4 | Status: RECRUITING